Omeros completes debt financing

Omeros Corp. (NASDAQ:OMER), Seattle, Wash.
Business: Inflammation, Neurology, Ophthalmic
Date completed:

Read the full 111 word article

User Sign In

Article Purchase

This article may not be distributed to non-subscribers

PURCHASE THIS ARTICLE FOR LIMITED ONE-TIME DISTRIBUTION AND WEBSITE POSTING $995.00 USD

PURCHASE